An Evaluation of the Safety of Pilots With Insulin-Treated Diabetes in Europe Flying Commercial and Noncommercial Aircraft
- 25 June 2020
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 43 (12), 2923-2929
- https://doi.org/10.2337/dc20-0277
Abstract
OBJECTIVE The risk of hypoglycemia in people with insulin-treated diabetes has debarred them from certain “safety-critical” occupations, including flying commercial aircraft. This report evaluates the effectiveness of a protocol enabling a large cohort of insulin-treated pilots to fly commercially. RESEARCH DESIGN AND METHODS This was an observational study of pilots with insulin-treated diabetes who were granted medical certification to fly commercial and noncommercial aircraft. Clinical details, pre- and in-flight (hourly and 30 min before landing) blood glucose values were correlated against the protocol-specified ranges: green (5–15 mmol/L), amber (low, 4–4.9 mmol/L; high, 15.1–20 mmol/L), and red (low, 20 mmol/L). RESULTS A total of 49 pilots with type 1 (84%) or type 2 (16%) diabetes who had been issued class 1 or class 2 certificates were studied. Median diabetes duration was 10.9 years. Mean HbA1c was 7.2% (55.0 mmol/mol) before certification and 7.2% (55.1 mmol/mol) after certification (P = 0.97). Blood glucose values (n = 38,621) were recorded during 22,078 flying hours. Overall, 97.69% of measurements were within the green range, 1.42% within the low amber range, and 0.75% within the high amber range. Only 0.12% of readings were within the low red range and 0.02% within the high red range. Out-of-range readings declined from 5.7% in 2013 to 1.2% in 2019. No episodes of pilot incapacitation occurred, and glycemic control did not deteriorate. CONCLUSIONS The protocol is practical to implement, and no events compromising safety were reported. This study represents what is, to our knowledge, the most extensive data set from people with insulin-treated diabetes working in a “safety-critical” occupation, which may be relevant when estimating risk in other safety-critical occupations.This publication has 13 references indexed in Scilit:
- A UK Civil Aviation Authority protocol to allow pilots with insulin-treated diabetes to fly commercial aircraftThe Lancet Diabetes & Endocrinology, 2017
- The U.S. Experience with Waivers for Insulin-Treated PilotsAerospace Medicine and Human Performance, 2017
- Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care, 2016
- Should a pilot on insulin really fly?The Lancet Diabetes & Endocrinology, 2014
- Would you fly with a pilot on insulin?The Lancet Diabetes & Endocrinology, 2014
- Fighting discriminationDiabetes Research and Clinical Practice, 2012
- The effects of acute hypoglycaemia on cognitive function in type 1 diabetesBritish Journal of Diabetes, 2012
- Relationships Between Hyperglycemia and Cognitive Performance Among Adults With Type 1 and Type 2 DiabetesDiabetes Care, 2005
- Acute Hyperglycemia Alters Mood State and Impairs Cognitive Performance in People With Type 2 DiabetesDiabetes Care, 2004
- A Survey of Cognitive Functioning at Different Glucose Levels in Diabetic PersonsDiabetes Care, 1983